Partially Blind Study to Evaluate Immunogenicity & Safety of GSK Bio's HPV Vaccine 580299 in Healthy Women Aged 9-25 Yrs
NCT00541970
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
961
Enrollment
INDUSTRY
Sponsor class
Conditions
Infections, Papillomavirus
Interventions
BIOLOGICAL:
Cervarix
DRUG:
Placebo
Sponsor
GlaxoSmithKline